Yinuokang Biopharma

医诺康

Yinuokang Biopharma

Biotech/Healthcare

Yinuokang is a Chinese-American joint venture focused on developing novel anti-cancer drugs. Founded in June 2021, its core management team collectively has decades of successful drug development experience, particularly in targeted protein degradation.

Latest round: Angel (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-05-01